Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Author:

Munshi Nikhil C.1,Anderson Larry D.1,Shah Nina1,Madduri Deepu1,Berdeja Jesús1,Lonial Sagar1,Raje Noopur1,Lin Yi1,Siegel David1ORCID,Oriol Albert1,Moreau Philippe1,Yakoub-Agha Ibrahim1ORCID,Delforge Michel1,Cavo Michele1,Einsele Hermann1,Goldschmidt Hartmut1,Weisel Katja1,Rambaldi Alessandro1,Reece Donna1,Petrocca Fabio1,Massaro Monica1,Connarn Jamie N.1,Kaiser Shari1,Patel Payal1,Huang Liping1,Campbell Timothy B.1,Hege Kristen1,San-Miguel Jesús1

Affiliation:

1. From the Jerome Lipper Multiple Myeloma Center, Dana–Farber Cancer Institute (N.C.M.), the Veterans Affairs Boston Healthcare System, Harvard Medical School (N.C.M.), and Massachusetts General Hospital (N.R.), Boston, and bluebird bio, Cambridge (F.P., M.M.) — all in Massachusetts; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas (L.D.A.); the University of California, San Francisco, San Francisco (N.S.); Icahn School of Medicine at Mount Sinai, New York (D.M....

Funder

Bristol-Myers Squibb

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3